Background: Adult porcine islets (APIs) constitute a promising alternative to human islets in treating type 1 diabetes. The intrahepatic site has been used in preclinical primate studies of API xenografts; however, an estimated two-thirds of donor islets are destroyed after intraportal infusion due to a number of factors, including the instant blood-mediated inflammatory reaction (IBMIR), immunosuppressant toxicity, and poor reestablishment of extracellular matrix connections. Intraperitoneal (ip) transplantation of non-vascularized encapsulated islets offers several advantages over intrahepatic transplantation of free islets, including avoidance of IBMIR, immunoprotection, accommodation of a larger graft volume, and reduced risk of hemorrhage. However, there exists evidence that the peritoneal site is hypoxic, which likely impedes islet function.
cadaveric pancreata and deleterious consequences of long-term immunosuppression limit the of number of patients that can be treated to a small fraction of the diabetic population. 3, 4 Xenotransplantation of porcine islets is a promising alternative for human islets, as pigs are an abundant source of pancreata, 5 pigs and humans have similar blood glucose levels, and porcine insulin differs from human insulin by only one amino acid. Hence, pigs are considered one of the most suitable xenogeneic sources of islets for potential clinical transplantation under immunosuppression. 6, 7 To improve immune acceptance and to reduce or eliminate the need for immunosuppression, porcine islets can be immunoprotected by micro-or macroencapsulation using biocompatible polymeric materials. 8 Recently, the field of cellular microencapsulation has been invigorated by new advancements, such as the development of alginate derivatives that inhibit the foreign body response and the demonstration that encapsulated human stem cell-derived beta cells can correct hyperglycemia in immunocompetent mice long term, without immunosuppression. 9, 10 The intraperitoneal cavity (ip) has been used as the transplantation site for encapsulated islet allografts 11, 12 and xenografts, 13 but long-term survival of these grafts has been difficult to achieve in this site. One likely reason is the hypoxic environment experienced by iptransplanted encapsulated islets. In native islets, whether human or porcine, insulin-secreting β cells are highly oxygenated by an extensive vascular glomerular-like network of capillaries that delivers arterial blood throughout the islets in vivo. 14 This vasculature is disrupted during islet isolation and cannot be re-established when islets are encapsulated. Therefore, transplanted islets must receive oxygen and other nutrients from the surrounding tissue by diffusion alone, and as a result, cells at the center of the islet are less oxygenated than cells at the periphery. In addition, the ip graft site is hypoxic, further reducing the oxygenation of cells in islets. Goh et al. reported that dissolved oxygen (DO) in the peritoneal cavity of mice (both normal and diabetic)
is in the range of 6.5%-7.3% O 2 (pO 2 : 49.21-55.27 mm Hg) and that DO decreases in a dose-dependent manner upon transplantation of encapsulated βTC-tet cells (a conditionally transformed mouse β-cell line) or encapsulated porcine islets. 15, 16 Other factors that can contribute to islet loss after transplantation include islet size, the percentage of acinar tissue in the graft, and the islet tissue oxygen consumption rate. 
| METHODS

| Materials
For API isolation from the pancreata of adult pigs, the following rea- 
| Animals
Pancreata from adult (>2 years of age) retired breeder sows (White Landrace) were provided by Drs. Lawrence Gazda and Robert
Holdcraft of the Rogosin Institute, Xenia, OH. All pancreas collection procedures were performed at Bob Evans Farms, Inc., in Xenia OH, under USDA regulation, as the pancreata were technically a by-product of the food production process.
| Islet isolation
API isolation was performed as described. 22 Briefly, the entire adult porcine pancreas was dissected ex situ and perfused with collagenase and protease in Xenia, OH, then transported commercially from Ohio to Emory University in Atlanta within about six h of cold ischemia time. In our laboratory at Emory, APIs were prepared by digesting the pancreas during static incubation with the enzyme. Briefly, the whole pancreas and collagenase/protease enzyme solution present during transport were placed in a sterile wire basket (500 μm mesh screen)
containing seven sterile marbles in a canister in a 32°C water bath.
Cold storage/purification solution was added to the basket, so the pancreas was covered by 4-5 inches of solution. When the pancreas appeared to be dissociating (by visual inspection), the digestion was stopped by adding HBSS with 10% heat-inactivated porcine serum (3 L) followed by dilution with HBSS and 2% porcine serum (18 L).
The digest was collected into 500-mL conical centrifuge tubes; each tube was centrifuged (233 G-force, 3 min at 4°C), and the pellets were pooled into one flask containing cold storage/wash solution, up to a total of <500 mL of digest. The digest was divided into two 250-mL conical tubes and the volume brought up to 250 mL with cold storage/purification solution and centrifuged (233 G-force, 3 min at 4°C).
The supernatant was aspirated from each of the two tubes, 20 mL of heat-inactivated porcine serum was added to each tube, HBSS was added to bring the volume to up 250 mL per tube, and the islets were purified by continuous density gradient purification on a Cobe 2991 at room temperature. The purified islets were cultured in suspension flasks in API medium.
| Islet quantitation
After overnight culture, all of the islets were pooled into one T-75 flask in a 50 mL volume, and islets in three aliquots of 50 μL each were quantitated by staining with dithizone and counting using an inverted phase contrast microscope with an ocular micrometer for sizing the islets. The total number of islets was determined by counting the The sum of the average IEQ (n=3) in each category was multiplied by the dilution factor (1000) to determine the total IEQ in the digested tissue. In our hands, the average yield was 799±133 IEQ per gram (n=13 isolations), which amounts to 240 000 IEQ for a 300-g adult porcine pancreas.
| Islet encapsulation
Islets were encapsulated in highly purified, low endotoxin (49 EU/g), low viscosity (52 mPa.s), high mannuronic acid (57%) (LVM) sodium alginate gelled with barium chloride (50 mmol/L) using a protocol modified from the methods of Duvivier-Kali et al. 23 For encapsulation, islets were centrifuged (149 G-force for 3 min) supernatant aspirated and islets were resuspended in 3.3% LVM sodium alginate (20 000 islets/1 mL alginate). Briefly, for Ba-gelled inhomogeneous alginate capsules, APIs in 3.3% sodium alginate were aspirated through a 16-gauge air jet encapsulation needle (pump speed 2 mL/min, air flow 6 L/min) and dropped into a bath containing 50 mmol/L BaCl 2 in 0.9% saline having 10 mmol/L 3-(N-morpholino) propane-sulfonic acid hemisodium salt, 140 mmol/L mannitol, and 0.025% Tween 20, on a magnetic stirrer. Gelling in mannitol rather than sodium chloride was used to form inhomogeneous alginate microcapsules. 24 The gelled capsules were incubated at room temperature in 50 mmol/L BaCl 2 for 5 min on a rotating platform and successively washed in 25 mmol/L BaCl 2 , 12.5 mmol/L BaCl 2 , followed by six washes with sterile saline. The diameter of the resulting Ba-gelled alginate capsules was 854±11 μm (range 830-880 μm, n=50). The encapsulated APIs were cultured for 24 hours at 37°C in a humidified atmosphere of 5% CO 2 in air before starting the experiment.
| Hypoxic chamber
A Lexan box (21.5 cm×12.5 cm×15.5 cm (custom designed at Georgia
Institute of Technology, Atlanta, GA, USA) was kept on an orbital shaker and housed in a CO 2 incubator at 37°C. Hypoxia was established by supplying continuously a gas mixture of 5% CO 2 balanced with N 2 through the chamber, lowering the oxygen to hypoxic levels in the range of 2%-5% O 2 (or 0.02-0.05 mmol/L). The oxygen concentration within the Lexan chamber was measured by an Orion 083005MD O 2 probe (Thermo Fisher Scientific, Middletown, NJ, USA). Prior to the study, the hypoxic chamber was equilibrated for at least 36 hours.
After the initiation of the study, to avoid temporary reoxygenation during medium changes, the medium was pre-equilibrated in the chamber for 24 hours prior to use.
| Experimental design
For each experiment, islets were isolated from one adult pig pancreas donor. Our experiments were repeated four times, each with islets from different islet isolation. Non-encapsulated APIs and Ba alginate-encapsulated APIs (both 60 IEQs/well of 48 well plate, six wells per condition) were cultured in API medium for 24 hours under normoxia (5% CO 2 and 21% O 2 at 37°C) before beginning the experiment, to allow cells to recover from isolation and encapsulation.
After this overnight culture (on day 0), alamar blue (AB) assays were performed to measure the metabolic activity of the islets at time zero, and these AB values were used subsequently for normalization. On day 0, all spent medium was removed and fresh medium was added to the appropriate plates (normoxic medium for plates to be cultured under normoxia or medium that had been pre-incubated under hypoxia, 2%-5% O 2 , for plates to be cultured under hypoxia). Next, the culture plates were incubated for 1, 3, and 6 days under normoxic or hypoxic conditions. For assays performed on days 3 and 6, culture media were changed on days 2 and 5. On days 1, 3, and 6, live/dead viability experiments were performed. On days 1 and 6, metabolic activity by alamar blue assays and quantification of secreted insulin in spent medium (500 μL, conditioned over 24 hours) was determined by porcine insulin ELISA.
| Islet viability assessment
Islet viability was evaluated with a viability/cytotoxicity assay using calcein AM (Ex 488 nm/Em 515 nm)/ethidium bromide (Ex 488 nm/ Em 610 nm) to detect live (green) and dead (red) cells on days 1, 3, and 6 of culture. Fluorescent images were captured under 10×magni-fication using a Zeiss LSM 510 UV Confocal Microscope (Carl Zeiss, Germany).
| Islet viability quantitation
To quantify the number of live (green) and dead (red) cells from confocal micrographs, spots-based analysis was performed using Imaris 
| Alamar blue (AB) assay
The alamar blue (AB) assay has been used to assess the effects of hypoxia on cellular metabolic activity. 25 In this study, we used the AB assay to measure the metabolic activity of APIs, whether free or encapsulated, under hypoxic and normoxic conditions. AB, a watersoluble dye, was chosen because it is non-toxic to cells and can be added as a sterile solution to viable cells in culture for continuous monitoring of the metabolic activity of cell cultures over time. 26 When added to cell cultures, the oxidized form of AB (resazurin) is converted within the cells to the reduced form (resorufin) by mitochondrial enzymes. As a result of this redox reaction, the culture medium changes from indigo blue to fluorescent pink, for analysis by fluorescence spectroscopy using a plate reader. 23 The metabolic activity under various conditions is reported as the AB ratio.
A sterile 10% non-fluorescent alamar blue (resazurin) solution in medium was added to APIs (five wells per condition) in a 96-well plate, and the plates were incubated in a standard 5% CO 2 incubator at 37°C for 3 hours. Due to the metabolic activity of the islets, the non-fluorescent resazurin was reduced to fluorescent resorufin; fluorescence was measured on a SpectraMax M2 multimode microplate reader (Molecular Devices, CA, USA) by exciting at 540 nm, and measuring the emission at 580 nm. Fluorescence intensity was reported in fluorescent arbitrary units (FAU).
The alamar blue assay was performed on days 0, 1, and 6. The results on days 1 and 6 were normalized to the fluorescence of day 0, which was measured immediately before the plates were placed under hypoxia or normoxia. These ratios henceforth will be referred to as AB ratios.
| Porcine insulin ELISA assay
To assess the effect(s) of hypoxia on islets, we chose to use insulin secretion as a measure of islet function. The insulin secreted over 24 h in spent medium was measured on days 1 and 6 using a porcine insulin ELISA kit. Insulin concentrations (ng/500 μL) were normalized to the corresponding day 0 alamar blue values and expressed as ng/ (500 μL*FAU).
| Statistics
Results were expressed as mean±SD. 
| RESULTS
| Effect of hypoxia on the viability of free and encapsulated APIs in vitro
To elucidate the effects of hypoxia on islet viability, and to determine whether encapsulation protects islets from the effects of hypoxia, we exposed free vs microencapsulated APIs to hypoxic conditions for 1, 3, and 6 days, and we assessed islet viability at each time point by staining with calcein AM and ethidium bromide. In parallel, free and encapsulated APIs were cultured under normoxia and stained, as controls.
Under hypoxia, the free islets began to dissociate and to lose viability after 1 day of culture, and these changes became more apparent by day 3. By day 6, very few viable, intact free islets remained under hypoxic conditions, but under normoxic conditions, a substantial number of free islets remained viable and intact ( Figure 1A,B) . By comparison, when islets were encapsulated, they remained intact under both hypoxia and normoxia until day 6. Under normoxic culture conditions, encapsulated islets maintained their integrity and viability for the six-day culture period ( Figure 1C ). However, in spite of maintaining their integrity, under hypoxic conditions, encapsulated islets began to die by day 3, and the loss of viability was more pronounced by day 6 ( Figure 1D ).
The confocal qualitative data are corroborated by the viability data 
| Effect of hypoxia on metabolic activity of free and encapsulated APIs in vitro
We evaluated the metabolic activity of APIs that were either free or encapsulated and cultured for either 1 or 6 days under normoxic vs hypoxic conditions. 
| Effect of hypoxia on insulin secretion by free and encapsulated APIs in vitro
To assess the effect(s) of hypoxia on the insulin secretory function of APIs over time, spent medium was assayed on days 1 and 6 of culture using a porcine insulin ELISA. On days 1 and 6 of culture, insulin secretion by F I G U R E 3 Metabolic activity as determined by the alamar blue assay of free and encapsulated APIs under normoxia and hypoxia. The experiments were performed four times, each with islets from separate islet isolation, and representative experiments are shown in A-C. The metabolic activity (fluorescence arbitrary unit FAU, n=5) was determined at each time point after being normalized to day 0 and is shown as the average±standard deviation (SD). Statistically significant differences (#, $ and *) among all groups (n=5 each) were performed using nonparametric ANOVA post hoc analysis (P≤.05). AB ratio is the ratio of fluorescence at each time point to the fluorescence of the same well at day 0. NF1 and NF6=free APIs under normoxia on days 1 and 6 of culture; HF1 and HF6=free APIs under hypoxia on days 1 and 6 of culture; NE1 and NE6=encapsulated APIs under normoxia on days 1 and 6 of culture; HE1 and HE6=encapsulated APIs under hypoxia on days 1 and 6 of culture
The viability of free and encapsulated APIs under normoxia and hypoxia. Representative results are shown in A-C. The viability was calculated by counting number of live (green) and dead (red) cells from confocal micrographs, and the results were expressed as average±standard deviation (SD). Statistically significant differences (*, #, $, @) between groups (n=3 confocal micrographs from each experimental condition) were determined using the unpaired Student's t test (P≤.05). NF1, NF3, NF6=free APIs under normoxia on days 1, 3, and 6 of culture; HF1, HF3, and HF6=free APIs under hypoxia on days 1, 3 and 6 of culture; NE1, NE3, and NE6=encapsulated APIs under normoxia on days 1, 3, and 6 of culture; HE1, HE3, and HE6=encapsulated APIs under hypoxia on days 1, 3, and 6 of culture both free and encapsulated islets was significantly lower under hypoxic 
| DISCUSSION
In this study, we evaluated the effects of hypoxic levels typically found in the peritoneal cavity of mice (2%-5% O 2 or pO 2 : 15.4- Metabolic activity is considered to be a marker for cell viability, and it can be determined by the alamar blue assay. 29 In our study, on day 1, there was no difference between the metabolic activity of free APIs under normoxia and hypoxia, but on day 6, the metabolic activity of free APIs under hypoxia was significantly lower relative to normoxia. De Groot study showed that after 5 days of hypoxia, the percentage of viable cells decreased to 62±9% relative to normoxia where viability was 96±0%. The loss of viability was associated with a substantial F I G U R E 4 Insulin secretion determined by ELISA of free and encapsulated under normoxia and hypoxia. The experiments were performed four times, each with islets from separate islet isolation, and representative experiments are shown in A-C. Insulin concentrations (ng/500 μL, n=3) at each time point were normalized to metabolic activity of the same well on day 0. Statistically significant differences ($, #, *) between two groups (n=3 each) using the unpaired Student's t test (P≤.05). The treatments indicated on the x-axis are the same as in Figure 3 increase in necrosis and a slight increase in apoptosis. 30 Emamaullee there was not a significant change in the insulin secretion rate.
34
We found that under normoxic conditions, the insulin levels in spent medium were significantly lower when the islets were encapsulated compared to free. Our data are in agreement with the findings of de Haan et al. 35 who showed that the presence of a capsule may interfere with the exchange of glucose and insulin during a glucosestimulated insulin release assay.
In our study, under hypoxic conditions, the viability of APIs was significantly improved by encapsulation, compared to free islets which exhibited severe cell death by day 6. There was a trend toward decreased metabolic activity in free as well as in encapsulated APIs.
Furthermore, insulin secretory function was significantly reduced by encapsulation under hypoxia. One possible explanation for our finding of reduced insulin secretion in spite of improved viability with encapsulation could be that the encapsulated islets were not lyzed, while the free islets had undergone necrosis and were lyzed. These lyzed islets likely released their stored insulin into the medium in contrast to the encapsulated islets which retained stored insulin.
The hypoxia-induced compromise of islet viability and function suggests that strategies protecting API grafts from in vivo hypoxic effects should be implemented. This is especially true for encapsulated islets because the literature suggests that gradients within the encapsulation matrix may further reduce oxygen availability for the islets. 36 Tactics that may be employed include the incorporation of CXCL12 in the capsules housing the islets 37 and using hypoxia-resistant teleost piscine islets 38 or NPIs 35 instead of APIs. Other strategies that have been implemented with various degrees of success include vascularizing the transplantation site by using islets which expresses vascular endothelial growth factors 39 or creating neovessels in a pouch, 40 employing oxygen-releasing biomaterials, 41 or incorporating photosynthetic microorganisms and a light source along with the islets.
42
In conclusion, our study shows that hypoxia representative of the murine peritoneal environment severely decreases API viability and metabolic activity as well as insulin secretion compared to normoxia,
We also conclude that under hypoxic conditions, encapsulation helps maintain islet integrity and viability, but our study shows that encapsulation does not improve metabolic activity or insulin secretion relative to free islets over a period of 6 days in culture.
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